- Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial. [Journal Article]Circulation. 2026 Aug 28. [Online ahead of print]Circ
- CONCLUSIONS: Multicomponent BP management strategy with a BP target <130/80 mm Hg led by NPCHPs achieved sustained BP control and reduced CVD risk during both the 7-year overall and 3-year posttrial periods.
- Publisher Full Text (DOI)
- Hypertension Control Programs: A Global Call to Action. [Editorial]Circulation. 2026 Aug 28. [Online ahead of print]Circ
- Publisher Full Text (DOI)
- Low Ventricular Chamber Stiffness Identifies a High-Risk Eccentric Remodeling Phenotype in the Fontan Circulation: A FORCE Registry Analysis. [Journal Article]Circulation. 2026 Aug 28. [Online ahead of print]Circ
- CONCLUSIONS: Contrary to prevailing assumptions, lower rather than higher chamber stiffness was associated with adverse Fontan outcomes, identifying a high-compliance phenotype characterized by ventricular dilation and eccentric remodeling. These findings suggest that, in the contemporary FORCE cohort, Fontan failure might be more closely associated with this remodeling phenotype than with progressive stiffening.
- Publisher Full Text (DOI)
- Structure-Function Relationship as the Foundation for Cardiac Myosin Inhibition in Hypertrophic Cardiomyopathy. [Journal Article]Circulation. 2026 Aug 28. [Online ahead of print]Circ
- Publisher Full Text (DOI)
- Defining Meaningful Treatment Responses in Hypertrophic Cardiomyopathy: Seeking a Trifecta Across Phenotypes. [Editorial]Circulation. 2026 Aug 28. [Online ahead of print]Circ
- Publisher Full Text (DOI)
- May the FORCE Be With You: Focusing on Ventricular Compliance in Fontan Failure. [Editorial]Circulation. 2026 Aug 28. [Online ahead of print]Circ
- Publisher Full Text (DOI)
- Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM. [Journal Article]Circulation. 2026 Aug 28. [Online ahead of print]Circ
- CONCLUSIONS: In patients with nHCM, aficamten was associated with improvements across a broad range of clinically relevant measures including symptom burden and diastolic function. These results underscore a potential benefit of aficamten in the population of patients with nHCM.
- Publisher Full Text (DOI)
- Coronary Artery Calcium (CAC): From Marker to Treatment Target? [Editorial]Circulation. 2026 Aug 28. [Online ahead of print]Circ
- Publisher Full Text (DOI)
- Cholecalciferol and Menaquinone Supplementation: Does Prevention of Coronary Artery Calcium Progression Mean Heart Benefit? [Editorial]Circulation. 2026 Aug 28. [Online ahead of print]Circ
- Publisher Full Text (DOI)
- Vitamin K2 and D3 Supplementation in Patients With Severe Coronary Artery Calcification: The DANCODE Trial. [Journal Article]Circulation. 2026 Aug 28. [Online ahead of print]Circ
- CONCLUSIONS: Among patients with severe CAC, supplementation with vitamin K2 and vitamin D3 reduced progression of CAC over 24 months. The reduction in calcification progression was not associated with an increase in noncalcified plaque volume.
- Publisher Full Text (DOI)
- Coronary Calcium Regression With Vitamin Supplementation: A Therapeutic Target or Too Good to be True? [Editorial]Circulation. 2026 Aug 28. [Online ahead of print]Circ
- Publisher Full Text (DOI)
- Fifth Universal Definition of Myocardial Infarction (2026): On Behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. [Journal Article]Circulation. 2026 Aug 27. [Online ahead of print]Circ
- Publisher Full Text (DOI)
- Transcriptomic Changes Elicited by Semaglutide in Human Ventricular Tissue Support Cell Survival and Lipid Metabolism. [Letter]Circ Heart Fail. 2026 Aug 27; :e014421. [Online ahead of print]CH
- Publisher Full Text (DOI)
- Sex Differences in Skeletal Muscle Inflammation and Dysfunction in Patients With Heart Failure and Reduced Ejection Fraction. [Journal Article]Circ Heart Fail. 2026 Aug 27; :e014062. [Online ahead of print]CH
- CONCLUSIONS: Skeletal muscle immune cell alterations, particularly macrophage and lymphocyte imbalances, are associated with muscle dysfunction in HFrEF, exhibiting distinct sex-specific patterns. These findings demonstrate sex-specific skeletal muscle inflammation and dysfunction in HFrEF.
- Publisher Full Text (DOI)
- Stepping Down Without Stepping Back: Financial Implications of Impella 5.5 Management on Cardiovascular Stepdown Units. [Journal Article]Circ Heart Fail. 2026 Aug 27; :e014055. [Online ahead of print]CH
- Publisher Full Text (DOI)